Sort
21,453 grants matching “tuberculosis”
Minnesota Tuberculosis Elimination and Laboratory Cooperative Agreement (CoAg)
$1,033,617Krissie Guerard · Minnesota State Dept Of Health · U52 · FY2015 · PS
JOHNS HOPKINS ADULT AIDS CLINICAL TRIALS UNIT
$1,032,476Johns Hopkins University · U01 · FY2004 · AI
Transmission Links and Clinical Spectrum of Exhaled Mycobacterium Tuberculosis
$1,032,233Yingda Linda Xie · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
Supported employment to create a community culture of SARS-CoV-2 rapid testing among people who inject drugs: PeerConnect2Test
$1,032,060Camille C Cioffi · University Of Oregon · U01 · FY2023 · DA
CIP Genomics Core
$1,032,059Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Mouse models for paucibacillary persistence
$1,031,737Sabine Ehrt · Weill Medical Coll Of Cornell Univ · U19 · FY2017 · AI
Genomics of bacterial pathogens: host response, persistence and transmission
$1,030,859Ashlee Miriam Earl · Broad Institute, Inc. · U19 · FY2017 · AI
Investigating alveolar macrophages in PLWH as targets for HIV persistence, residual inflammation and immune activation
$1,030,790Jyothi Rengarajan · Emory University · R01 · FY2025 · AI
Caribbean, Central and South America network for HIV epidemiology (CCASnet)
$1,030,748Catherine C McGowan · Vanderbilt University · U01 · FY2015 · AI
GHESKIO HIV Clinical Trial Unit
$1,030,670Jean William Pape · Gheskio Center · UM1 · FY2017 · AI
Core 3: Biocontainment Research Support Services Core
$1,029,538Colin S. Duckett · Duke University · UC7 · FY2023 · AI
Influence of SIV replication on TB progression and immunity
$1,029,305Zandrea Ambrose · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI
Biomarker Signatures of TB Infection in Young Children With and Without HIV
$1,028,909Padmini Salgame · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI
Exploration, conservation, & development of marine biodiversity in Fiji and the S
$1,028,666Mark E Hay · Georgia Institute Of Technology · U19 · FY2014 · TW
Bacterial Mechanisms and Host Pharmacokinetic Factors that Determine Persistence
$1,028,211David Alland · Boston Medical Center · U19 · FY2016 · AI
An adjuvant that promotes TH1/TH17 and CD8 T cells in a tuberculosis vaccine
$1,027,582Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · AI
A Handheld Microchip for GC analysis of breath to screen for COVID-19
$1,026,672Xiao-An Fu · University Of Louisville · U18 · FY2021 · TR
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
$1,026,345Ann R Falsey · University Of Rochester · UM1 · FY2023 · AI
Validation of Biomarkers of Pediatric TB and further development for use in diagnosis of childhood TB
$1,026,331Michael Levin · Imperial College Of Science, Technology And Medicine · R01 · FY2019 · AI
CENTER FOR AIDS RESEARCH (CFAR)
$1,025,955Case Western Reserve University · P30 · FY2000 · AI
Tuberculosis Research Unit
$1,025,723W. Henry Boom · Case Western Reserve University · N01 · FY2012 · AI
PEDIATRIC AIDS CLINICAL TRIALS UNIT
$1,025,528New York University School Of Medicine · U01 · FY2001 · AI
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study
$1,025,117Adithya Cattamanchi · University Of California-Irvine · R01 · FY2024 · AI
Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging
$1,024,684Robert A Salata · Case Western Reserve University · U54 · FY2020 · CA
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$1,023,963Kathryn Hafford · Virginia State Dept Of Health · U52 · FY2007 · PS